We believe that increasing our research efforts now will significantly speed up the time taken to find new treatments for everyone living with MS.
We’re working in collaboration with researchers from across the UK to build a clinical trials ‘platform’. The platform will provide a structure through which trials of both re-purposed and novel drugs can be run faster and more cost efficiently. This new type of trial will allow us to:
- Test multiple drugs at once
- Try combinations of treatments that target different mechanisms, like myelin repair and neuroprotection
- Add new treatments as they’re discovered
- Stop testing drugs that aren’t working
- Move seamlessly through trial phases
The Stop MS Appeal offers huge potential to accelerate the development of new treatments through this innovative approach. It will mean we can continually adapt and improve the trial, so new participants can be given the best potential treatments. It also means we can try to match people with the treatment that suits their individual situation.
With the right funding, by 2025 we plan to be in the final stages of testing for a range of treatments for relapsing and progressive forms of MS.
Contact our Research team
Read past editions of Teamspirit
Don't forget we always want to hear from you - send us your stories:
